Article
Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment.
Proceedings of the National Academy of Sciences of the United States of America - 2 Jun 2009
Harrington W E, Mutabingwa T K, Muehlenbachs A, Sorensen B, Bolla M C, Fried M, Duffy P E
Abstract excerpt
Intermittent preventive treatment in pregnancy (IPTp) is used to prevent Plasmodium falciparum malaria. However, parasites resistant to the IPTp drug sulfadoxine-pyrimethamine (SP) have emerged worldwide, and infections with mixed resistant and susceptible parasites are exacerbated by pyrimethamine in mice. In a prospective delivery cohort in Muheza, Tanzania, we examined the effects of SP IPTp on parasite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
